SC
Squadron Capital Management LLC cut its RLMD stake below 5%
Squadron Capital Management LLC reported owning 3.3% of Relmada Therapeutics, Inc. (RLMD) (3,500,000 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G